Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,209Revenue $M3,029Net Margin (%)-4.9Z-Score0.7
Enterprise Value $M7,159EPS $-1.1Operating Margin %3.2F-Score4
P/E(ttm))0Cash Flow Per Share $11.8Pre-tax Margin (%)-4.1Higher ROA y-yN
Price/Book2.510-y EBITDA Growth Rate %0Quick Ratio1.6Cash flow > EarningsY
Price/Sales1.15-y EBITDA Growth Rate %0Current Ratio2.1Lower Leverage y-yY
Price/Cash Flow1.6y-y EBITDA Growth Rate %-8.7ROA % (ttm)-2.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-7.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M83.6ROI % (ttm)-6.6Gross Margin Increase y-yN

Gurus Latest Trades with ALR

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ALRJoel Greenblatt 2014-09-30 Sold Out -0.01%$34.26 - $41.14
($37.35)
$ 38.43%Sold Out0
ALRJohn Keeley 2014-06-30 Buy 0.9%$32.86 - $37.68
($35.57)
$ 38.48%New holding, 1335700 sh.1,335,700
ALRMario Gabelli 2014-06-30 Add0.03%$32.86 - $37.68
($35.57)
$ 38.48%Add 206.84%242,845
ALRJoel Greenblatt 2014-06-30 Buy 0.01%$32.86 - $37.68
($35.57)
$ 38.48%New holding, 11057 sh.11,057
ALRMario Gabelli 2014-03-31 Add0.01%$33.99 - $39.34
($36.55)
$ 38.45%Add 646.65%79,145
ALRPrivate Capital 2013-09-30 Reduce-1.54%$24.38 - $34.49
($30.53)
$ 38.426%Reduce -41.64%927,844
ALRPrivate Capital 2012-06-30 Add0.71%$17.98 - $25.97
($20.85)
$ 38.484%Add 35.93%1,734,463
ALRMario Gabelli 2012-06-30 Reduce$17.98 - $25.97
($20.85)
$ 38.484%Reduce -25.93%10,000
ALRSeth Klarman 2012-06-30 Sold Out -0.12%$17.98 - $25.97
($20.85)
$ 38.484%Sold Out0
ALRSeth Klarman 2012-03-31 Reduce-1.3%$22.21 - $26.64
($22.87)
$ 38.468%Reduce -93.12%137,700
ALRMario Gabelli 2011-12-31 Reduce$18.51 - $26.43
($23.09)
$ 38.466%Reduce -27.03%13,500
ALRSeth Klarman 2011-12-31 Reduce-0.72%$18.51 - $26.43
($23.09)
$ 38.466%Reduce -35.48%2,000,000
ALRDavid Dreman 2011-12-31 Sold Out -0.53%$18.51 - $26.43
($23.09)
$ 38.466%Sold Out0
ALRPrivate Capital 2011-09-30 Add0.27%$20.62 - $38.43
($27.49)
$ 38.440%Add 13.49%1,353,656
ALRPrivate Capital 2011-06-30 Add0.14%$33.98 - $41
($38.19)
$ 38.40%Add 5.74%1,192,781
ALRGeorge Soros 2011-06-30 Sold Out $33.98 - $41
($38.19)
$ 38.40%Sold Out0
ALRGeorge Soros 2011-03-31 Reduce$36.17 - $40.32
($38.34)
$ 38.40%Reduce -29.29%14,000
ALRMario Gabelli 2011-03-31 Reduce-0.03%$36.17 - $40.32
($38.34)
$ 38.40%Reduce -77.58%18,500
ALRSeth Klarman 2010-12-31 Add3.38%$28.14 - $36.39
($31.64)
$ 38.421%Add 106.67%3,100,000
ALRGeorge Soros 2010-12-31 Add$28.14 - $36.39
($31.64)
$ 38.421%Add 45.59%19,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ALR is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ALR Mario Gabelli 2014-09-30263,7700.320.06+8.62%
ALR John Keeley 2014-09-301,342,6151.611.1+0.52%
ALR Private Capital 2014-09-30908,4531.094.2-1.36%
ALR Joel Greenblatt 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ALR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BRIDGEN JOHNSr VP, Business Develop 2014-12-11Sell50,000$37.073.59view
Teitel DaveCFO 2014-08-15Sell10,000$35.079.5view
Torchilin KateVP, Connected Health 2013-12-11Sell8,547$33.7313.85view
HEMPEL PAUL TSVP Ethics & Compliance 2013-11-13Sell4,576$33.7413.81view
Powers Gregg JDirector 2013-08-19Sell0$013.81view
Flakne CarlaChief Accounting Officer 2013-08-19Sell0$013.81view
Teitel DaveCFO 2013-08-15Sell10,000$31.7321.02view
Keyes CraigGlobal Pres, Health Info. Solu 2013-08-09Sell0$021.02view
Cotton Michael LesterGlobal Pres, Health Mgmt 2013-08-05Sell12,500$33.8213.54view
Cotton Michael LesterGlobal Pres, Health Mgmt 2013-05-31Sell8,750$25.8648.49view

Press Releases about ALR :

    Quarterly/Annual Reports about ALR:

    News about ALR:

    Articles On GuruFocus.com
    DENTSPLY´s Growth Opportunities Dec 16 2014 
    Hologic Produces the First FDA-Approved 3D Mammography Platform Nov 26 2014 
    Mario Gabelli Comments on Alere Inc Nov 21 2014 
    Mario Gabelli’s Asset Fund Q3 2014 Commentary Nov 21 2014 
    Cohen Has Busy Third Quarter Nov 19 2014 
    Alder Reports Encouraging Copper and Gold Metallurgical Recovery Results for the Stockpiles and Tail Nov 05 2014 
    Diamond Hill Capital Comments on Alere Inc Oct 17 2014 
    Diamond Hill Select Fund Third Quarter 2014 Commentary Oct 17 2014 
    John Keeley Discloses Top New Stock Buys of Q2 Sep 17 2014 
    Carl Icahn Bets on Hologic; Should You? Aug 19 2014 

    More From Other Websites
    Current report drafted according to the provisions of the article 226 of the Law no. 297/2004 Dec 19 2014
    Current report before Alro's EGSM January 29, 2015 Dec 19 2014
    Altera Demonstrates Industry’s Highest Performance DDR4 Memory Data Rates in an FPGA Dec 18 2014
    Conditional registration of shares in NDS Dec 18 2014
    Satisfying a condition precedent to the share sale agreement concerning the shares of Meritum Bank... Dec 16 2014
    Alere (ALR) Downgraded From Buy to Hold Dec 14 2014
    Alere's HIV Combo Test Gets CLIA Waiver from the FDA Dec 11 2014
    Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock Dec 10 2014
    Altera Issues 2015 Guidance Dec 10 2014
    U.S. Food and Drug Administration Grants CLIA Waiver for Alere Determine™ HIV-1/2 Ag/Ab Combo Test Dec 09 2014
    Alere Initiates Voluntary URGENT CORRECTION for Use of Alere INRatio® and INRatio®2 PT/INR Monitor... Dec 08 2014
    List of shareholders with at least 5% voting rights at the Extraordinary General Meeting of Alior... Dec 04 2014
    ALERE INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and... Dec 03 2014
    Satisfying a condition precedent to the share sale agreement concerning the shares of Meritum Bank... Dec 02 2014
    Declaration on subscription for shares, execution of an Incentive Scheme Nov 28 2014
    Alere Appoints Juliet Cunningham to Lead Investor Relations Nov 21 2014
    Alere Appoints Juliet Cunningham to Lead Investor Relations Nov 21 2014
    Alere to Participate in Jefferies Global Healthcare Conference Nov 18 2014
    Concluding an annex to the subscription agreement for new shares of the Bank Nov 17 2014
    Altera and IBM Unveil FPGA-accelerated POWER Systems with Coherent Shared Memory Nov 17 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK